Investors with a lot of money to spend have taken a bearish stance on LifeMD (NASDAQ:LFMD).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with LFMD, it often means somebody knows something is about to happen.
So how do we know what these investors just did?
Today, Benzinga's options scanner spotted 9 uncommon options trades for LifeMD.
This isn't normal.
The overall sentiment of these big-money traders is split between 22% bullish and 77%, bearish.
Out of all of the special options we uncovered, 5 are puts, for a total amount of $222,173, and 4 are calls, for a total amount of $129,180.
Projected Price Targets
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $7.5 to $11.0 for LifeMD during the past quarter.
Volume & Open Interest Development
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for LifeMD's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of LifeMD's whale activity within a strike price range from $7.5 to $11.0 in the last 30 days.
LifeMD Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
About LifeMD
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
Following our analysis of the options activities associated with LifeMD, we pivot to a closer look at the company's own performance.
Current Position of LifeMD
- With a volume of 1,595,655, the price of LFMD is down -22.79% at $9.52.
- RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
- Next earnings are expected to be released in 90 days.
Professional Analyst Ratings for LifeMD
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $14.5.
- Consistent in their evaluation, an analyst from Cantor Fitzgerald keeps a Overweight rating on LifeMD with a target price of $15.
- An analyst from BTIG persists with their Buy rating on LifeMD, maintaining a target price of $14.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for LifeMD, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
